Author: Piers Townley

Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate

Former Cabinet minister Tessa Jowell led a debate in the House of Lords yesterday where she asked the Government to support her call for an acceleration of new cancer treatments and improvements in patient care

Our Policy & Public Affairs Manager Cameron Miller, reflects of Tessa Jowell’s moving House of Lords debate today

In her interview on the Today programme, Tessa Jowell talked about adaptive clinical trials. Find out more

Former cabinet Minister Tessa Jowell appeared on the Today programme this morning talking about her brain tumour diagnosis and need for more research into the disease

Former cabinet Minister Tessa Jowell will speak out for the first time later this week about her brain tumour diagnosis as she spearheads a public debate about cancer treatments and life expectancy

A study involving multiple institutions in the United States reported that conventional cancer therapy initiates a series of events that encourage living cancer cells to grow and develop new tumours

Our Young Ambassador Chandos Green is set to take on the challenge of his life

This March, we are aiming to raise £150,000 to fund a life-saving research project for over two years

Researchers have discovered that the circadian rhythm, also known as a person’s ‘internal clock’, could hold the answers to develop new therapies for glioblastoma

Pioneering web-app will help patients and researchers

Scotland-based charity, Worldwide Cancer Research, has formed a unique partnership with us to fund two outstanding scientists’ work on brain cancer

Research funded by The Brain Tumour Charity has proved for the first time that a naturally-occurring virus can cross the blood-brain barrier in humans and attack tumour cells in the brain

Our Policy & Public Affairs Manager Cameron Miller outlines why 2017 was a fantastic year for the Policy Team at The Brain Tumour Charity

Patients with glioblastoma are wearing a cap that delivers electronic fields to treat their brain tumours

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Researchers at UC San Francisco develop a vaccine to treat diffuse midline glioma by using the patient’s immune system to attack the tumour cells

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Yesterday, along with partners of the Less Survivable Cancers Taskforce, we met with Government Minister Steve Brine, Parliamentary Under-Secretary (Department of Health)

The Neuro-Oncology team at King’s College Hospital are excited to welcome Charlotte Robinson into the first low grade glioma CNS post in the UK

PAC-1, an anti-cancer drug is approved for phase 1(b) clinical trials in humans by the US Food and Drug Administration

On Thursday Alexander Stewart MSP led a debate in the Scottish Parliament on Brain Tumour Awareness in Scotland, as several MSPs expressed their support for action to raise greater awareness of the disease

Our Policy & Public Affairs Manager Cameron Miller, outlines tomorrow’s MSP debate in the Scottish Parliament

In the UK, 11,000 people are diagnosed with a brain tumour every year. This figure simply has to change